Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2025-12-29 @ 5:52 PM
Study NCT ID:
NCT05993858
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-15
First Post:
2023-07-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10-20
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-12-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-20
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-19
First Submit QC Date:
None
Study First Post Date:
2023-08-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-06
Last Update Post Date:
2023-08-15
Last Update Post Date Type:
ACTUAL